Home » Topics » BioWorld Science

BioWorld Science
RSS

Daiichi Sankyo opens enrollment for phase II study of valemetostat in relapsed/refractory ATL

Nov. 14, 2019

SQZ-PBMC-HPV begins phase I study in HPV+ recurrent, locally advanced or metastatic solid tumors

Nov. 14, 2019

Pivotal study of Nucala in hypereosinophilic syndrome meets primary endpoint

Nov. 14, 2019

Phase IIa study of THX-110 in obstructive sleep apnea meets primary endpoint

Nov. 14, 2019

Bacteriophage "cocktail" fights drinking sequelae, PSC

Nov. 14, 2019

Phase I/II study of DF-1001 in advanced HER2-expressing sold tumors begins dosing

Nov. 14, 2019

Sichuan Kelun-Biotech Biopharmaceutical identifies new arginase-1 inhibitors

Nov. 14, 2019

Shanghai Leadopharma Technology presents antiepileptic compounds

Nov. 14, 2019

Sumitomo Dainippon Pharma patents mGlu2 receptor negative allosteric modulators

Nov. 14, 2019

AlaMab Therapeutics discloses connexin-43 antibodies

Nov. 14, 2019

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 26, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 23, 2026
Brain-computer interfaces are here but long road ahead
BioWorld
The field of BCI is continually evolving; as such, companies are increasingly highlighting the potential of their technologies to transform care. For advanced...
2026 marks critical turning point for BCI technology
BioWorld
Decades of research are helping unravel the “black box” of the brain. The second article in BioWorld’s series on the Brain-Computer Interface (BCI) field looks at...
Case report links APOLD1 variant to vascular-type bleeding disorder
BioWorld Science
Vascular-type bleeding disorder (BDVAS) is a rare, autosomal dominant disorder mainly caused by impaired vascular integrity.